| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.092 | 0.06 |